Role of Ayurveda medicine in AMLAPITTA

Phase 2

Not yet recruiting

• Conditions: Acute peptic ulcer, site unspecified, without hemorrhage or perforation,

• Registration Number: CTRI/2019/08/020958
• Lead Sponsor: National Institute of Ayurveda

Brief Summary

*Amlapitta* is a clinical condition which has become a common problem for most of the people in this modern era. Due to changed life style, increased pace of life, stress as well as changes in food habits. The prevalence rate of gastritis in india is around 10 millions. The risk  factors like spicy food ,alcohol,aspirin,other NSAID’s ,or any gastric mucosa by inhibiting prostaglandins, gastric bi-carbonates and mucous secretions and alters the mucosal micro circulation.

This produces symptom like heart burn, sour belching, acid eructation, anorexia and nausea. This leads to acute gastritis and if left unattended in the chronic stage it leads to gastric or duodenal ulcers, followed by perforation if untreated. The remedies in biomedicine are acid suppressive agents like H2 receptors antagonists, proton- pump inhibiters etc. These are working temporarily without any permanent solution as well as having adverse effects after long standing usage. Hence we shall consider the *chikista sutra* *kaphapittahara vidhi* described by *Yogaratnakar* to overcome the disease and the selected drug is the *Pippali ghrit* described by *Chakradatta* to overcome the disease and the selected drug *Pippali ghrit* containing *pippali kawath, pippali kalak* and *gou ghrit* and *Pittantak yog* containing *Sitopala, Amrit dhara, Sudh Savaran gairik* having *seetvirya, madhura rasa* and *pittasamaka*and *agnidipaka guna*.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-02-09
• Last Update Posted: 2019-08-28

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• 1.Patient between 16years to 60years.
• 2.Patients of classical Amlapitta symptoms, irrespective of gender, caste, occupation and economic status.
• 3.Amlapitta of any dosha anubandha (associated doshah).

Exclusion Criteria

• 1.Patient below 16 and above 60 years of age.
• 2.Patients with complication of acute or chronic gastritis like peptic ulcer any secondary infections or syndromes and medical emergencies.
• 3.Pregnant women or lactating mothers.
• 5.Patient along with diabetes, HTN,COPD, Malignancy.
• 6.Complication which intervenes the course of treatment.
• 7.Patient on chemo and radiotherapy for malignancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in symptoms of Amlapitta.	baseline, 15 days, 30 days.

Secondary Outcome Measures

Name	Time	Method
Measurement of Amlapitta (Acidity) severity.	baseline, 15 days, 30 days

Trial Locations

Locations (1)

National Institute of Ayurveda, Jaipur; 🇮🇳 Jaipur, RAJASTHAN, India

National Institute of Ayurveda, Jaipur

🇮🇳Jaipur, RAJASTHAN, India

Dr Mahendra Kaswan

Principal investigator

9352763122

kaswanmahendra@gmail.com